A mouse model of episodic ataxia type-1

Nature Neuroscience

Volumn 6, Issue 4, 2003, Pages 378-383

  Herson, Paco S ^a   Virk, Michael ^b   Rustay, Nathan R ^a   Bond, Chris T ^a   Crabbe, John C ^a,c   Adelman, John P ^a   Maylie, James ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETAZOLAMIDE; POTASSIUM CHANNEL;

4 AMINOBUTYRIC ACID RELEASE; ALLELE; AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; AUTOSOMAL DOMINANT DISORDER; CEREBELLUM; CHANNEL GATING; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; FEMALE; FREQUENCY MODULATION; GABAERGIC SYSTEM; GENE MUTATION; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; STRESS;

ACETAZOLAMIDE; ACTION POTENTIALS; ANIMALS; CARBONIC ANHYDRASES; CELL MEMBRANE; CEREBELLUM; DISEASE MODELS, ANIMAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; GENES, LETHAL; KV1.1 POTASSIUM CHANNEL; MALE; MICE; MICE, TRANSGENIC; MUTATION; NEURAL INHIBITION; NEURONS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; PURKINJE CELLS; SPINOCEREBELLAR DEGENERATIONS; STRESS; SYNAPSES; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 0345074135     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1025     Document Type: Article

References (27)

1. Browne, D. L. et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene KCNA1. Nat. Genet. 8, 136-140 (1994).
2. Gancher, S. & Nutt, J. Autosomal dominant episodic ataxia: a heterogeneous syndrome. Mov. Disord. 1, 239-253 (1986).
3. Brunt, E.R. & Weeden, T.W.V. Familial paroxysmal kinesigenic ataxia and continuous myokymia. Brain 113, 1361-1382 (1990).
4. Adelman, J.P., Bond, C.T., Pessia, M. & Maylie, J. Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron 15, 1449-1454 (1995).
5. Maylie, B., Bissonnette, E., Virk, M., Adelman, J.P. & Maylie, J.G. Episodic ataxia type-1 mutations in the human Kv1.1 potassium channel alter hKvβ1-induced N-type inactivation. J. Neurosci. 22, 4786-4793 (2002).
6. D'Adamo, C.M., Liu, Z., Adelman, J.P., Maylie, J. & Pessia, M. Episodic ataxia type-1 mutations in the hKv1.1 cytoplasmic pore region alter the gating properties of the channel. EMBO J. 17, 1200-1207 (1998).
7. Zerr, P., Adelman, J.P. & Maylie, J. Episodic ataxia mutations in Kv1.1 alter potassium channel function by dominant negative effects and haploinsufficiency. J. Neurosci. 18, 2842-2848 (1998).
8. + channels in terminal and juxtaparanodal regions of neurons. Nature 365, 75-79 (1993).
9. Hallows, J.L. & Tempel, B.L. Expression of Kv1.1, a Shaker-like potassium channel, is temporally regulated in embryonic neurons and glia. J. Neurosci. 18, 5682-5691 (1998).
10. Smart, S.L. et al. Deletion of the Kv1.1 potassium channel causes epilepsy in mice. Neuron 20, 809-819 (1998).
11. Rustay, N.R., Wahlsten, D. & Crabbe, J.C. Influence of task parameters on rotarod performance and sensitivity to ethanol in mice. Behav. Brain Res. (in press).
12. Zhang, C.L., Messing, A. & Chiu, S.Y. Specific alteration of spontaneous GABAergic inhibition in cerebellar Purkinje cells in mice lacking the potassium channel Kv1.1. J. Neurosci. 19, 2852-2864 (1999).
13. + channel mRNAs in the rat brain and down-regulation in the hippocampus following seizures. Neuron 8, 1055-1067 (1992).
14. Wang, H., Kunkel, D.D., Martin, T.M., Schwartzkroin, P.A. & Tempel, B.L. Localization of Kv1.1 and Kv1.2, two channel proteins, to synaptic terminals, somata and dendrites in the mouse brain. J. Neurosci. 14, 4588-4599 (1994).
15. 2+ signals in axons of basket cells from rat cerebellar slices. J. Physiol. 502, 509-519 (1997).
16. 2+ concentration rises in rat cerebellar basket cell axons. J. Physiol. 520, 65-78 (1999).
17. Zhou, L. & Chiu, S.Y. Computer model for action potential propagation through branch point in myelinated nerves. J. Neurophysiol. 85, 197-210 (2001),
18. Llano, I. & Gerschenfeld, H.M. β-adrenergic enhancement of inhibitory synaptic activity in rat cerebellar stellate and Purkinje cells. J. Physiol. 468, 201-224 (1993).
19. Alger, B.E. & Nicoll, R.A. Pharmacological evidence for two kinds of GABA receptor on rat hippocampal pyramidal cells studied in vitro. J. Physiol. 328, 125-141 (1982).
20. Ben-Ari, Y., Cherubini, E., Corradetti, R. & Gaiarsa, J.L. Giant synaptic potentials in immature rat CA3 hippocampal neurones. J. Physiol. 416, 303-325 (1989).
21. A receptors in the hippocampus. Science 253, 1420-1423 (1991).
22. Buhl, E.H., Halasy, K. & Somogyi, P. Diverse sources of hippocampal unitary inhibitory postsynaptic potentials and the number of synaptic release sites. Nature 368, 823-828 (1994).
23. A receptors. Science 269, 977-981 (1995).
24. Sun, M., Dahl, D. & Alkon, D.L. Heterosynaptic transformation of GABAergic gating in the hippocampus and effects of carbonic anhydrase inhibition. J. Pharmacol. Exp. Ther. 296, 811-817 (2001).
25. Munsch, T. & Pape, H.C. Upregulation of the hyperpolarization-activated cation current in rat thalamic relay neurones by acetazolamide. J. Physiol. 519, 505-514 (1999).
26. Schwenk, F., Baron, U. & Rajewsky, K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080-5081 (1995).
27. Vincent, P., Armstrong, C.M. & Marty, A. Inhibitory synaptic currents in rat cerebellar purkinje cells: modulation by postsynaptic depolarization. J. Physiol. 456, 453-471 (1992).